Research Article

Cardioprotection against Ischemia/Reperfusion by Licochalcone B in Isolated Rat Hearts

Table 1

Effect of licochalcone B on cardiac function in rats subjected to I/R (values are means with their standard deviation, ).

Physical indexReperfusion (%)
15 min30 min45 min

LVDP
 Control96.31 ± 3.2794.45 ± 4.1293.67 ± 4.92
 I/R40.50 ± 4.59##47.18 ± 4.08##48.76 ± 5.88##
 0.5 μg/mL licochalcone B79.76 ± 2.06**78.28 ± 3.79**74.13 ± 5.39**
 1 μg/mL licochalcone B85.39 ± 2.73**82.23 ± 2.83**81.49 ± 3.41**
 3 μg/mL licochalcone B63.88 ± 5.54*57.46 ± 3.99*55.16 ± 2.53*
 5 μg/mL licochalcone B58.54 ± 3.9752.96 ± 3.8251.10 ± 4.28
 Control117.68 ± 2.59116.79 ± 3.63113.03 ± 3.71
 I/R42.26 ± 3.27##52.83 ± 3.41##52.62 ± 3.92##
 0.5 μg/mL licochalcone B68.48 ± 4.84*75.29 ± 7.46*74.59 ± 4.40*
 1 μg/mL licochalcone B95.11 ± 3.50**95.76 ± 1.84**92.27 ± 2.94**
 3 μg/mL licochalcone B61.05 ± 4.83*60.36 ± 4.50*57.68 ± 3.66*
 5 μg/mL licochalcone B55.90 ± 3.60*55.09 ± 2.10*54.22 ± 3.97*
 Control102.69 ± 3.7299.30 ± 4.9397.35 ± 5.01
 I/R49.22 ± 5.88##56.47 ± 3.28##56.05 ± 4.49##
 0.5 μg/mL licochalcone B72.96 ± 5.38*74.12 ± 2.42*66.78 ± 5.68*
 1 μg/mL licochalcone B85.60 ± 2.40**83.62 ± 5.14**84.76 ± 7.00**
 3 μg/mL licochalcone B54.59 ± 6.85*53.50 ± 5.25*50.12 ± 5.55*
 5 μg/mL licochalcone B49.80 ± 4.9148.27 ± 2.9647.90 ± 4.25
CF
 Control107.34 ± 3.16107.09 ± 3.53104.18 ± 5.97
 I/R90.57 ± 8.78#100.72 ± 7.65#99.92 ± 10.00#
 0.5 μg/mL licochalcone B98.83 ± 1.7898.72 ± 4.8999.99 ± 3.45
 1 μg/mL licochalcone B95.52 ± 6.1897.95 ± 5.9198.22 ± 7.16
 3 μg/mL licochalcone B85.84 ± 3.91*90.73 ± 8.34*92.49 ± 7.77*
 5 μg/mL licochalcone B89.78 ± 5.44*90.07 ± 7.32*91.88 ± 3.67*
HR
 Control118.13 ± 8.05118.96 ± 3.81122.56 ± 3.91
 I/R86.49 ± 10.97##78.49 ± 8.81##69.00 ± 3.50##
 0.5 μg/mL licochalcone B94.99 ± 8.9093.01 ± 11.05*86.99 ± 1.34*
 1 μg/mL licochalcone B105.46 ± 8.29*100.55 ± 9.07**97.07 ± 4.36**
 3 μg/mL licochalcone B97.86 ± 8.5389.68 ± 6.4786.47 ± 5.02
 5 μg/mL licochalcone B87.00 ± 9.4080.49 ± 8.9874.13 ± 3.57

Left ventricular developed pressure (LVDP); maximum rise velocity (); maximum down velocity (); coronary flow (CF); heart rate (HR). and compared with control group; and compared with the I/R group.